Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity.

Kuo SH, Yeh KH, Chen LT, Lin CW, Hsu PN, Hsu C, Wu MS, Tzeng YS, Tsai HJ, Wang HP, Cheng AL.

Blood Cancer J. 2014 Jun 20;4:e220. doi: 10.1038/bcj.2014.40.

2.

Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior.

Huang WT, Kuo SH, Cheng AL, Lin CW.

Mod Pathol. 2014 Aug;27(8):1116-25. doi: 10.1038/modpathol.2013.229.

3.

Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.

Delchier JC, Lamarque D, Levy M, Tkoub EM, Copie-Bergman C, Deforges L, Chaumette MT, Haioun C.

Am J Gastroenterol. 2001 Aug;96(8):2324-8.

PMID:
11513169
4.

Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.

Kuo SH, Yeh KH, Wu MS, Lin CW, Hsu PN, Wang HP, Chen LT, Cheng AL.

Blood. 2012 May 24;119(21):4838-44; quiz 5057. doi: 10.1182/blood-2012-01-404194.

5.

Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.

Kuo SH, Cheng AL.

Hematology Am Soc Hematol Educ Program. 2013;2013:109-17. doi: 10.1182/asheducation-2013.1.109. Review.

PMID:
24319171
6.

Helicobacter pylori eradication in gastric diffuse large B cell lymphoma.

Paydas S.

World J Gastroenterol. 2015 Apr 7;21(13):3773-6. doi: 10.3748/wjg.v21.i13.3773. Review.

7.

A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.

Li X, Xia B, Guo S, Zhan Z, Zhang L, Zhao D, Wu X, Zhang Y.

Ann Hematol. 2013 Jun;92(6):807-15. doi: 10.1007/s00277-013-1701-9.

PMID:
23417758
8.

High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.

Cavanna L, Pagani R, Seghini P, Zangrandi A, Paties C.

World J Surg Oncol. 2008 Mar 19;6:35. doi: 10.1186/1477-7819-6-35. Review.

9.

Helicobacter pylori-associated gastric lymphoma in a girl.

Sharon N, Kenet G, Toren A, Mandel M, Neumann Y, Kaplinsky C, Schiby G, Rechavi G.

Pediatr Hematol Oncol. 1997 Mar-Apr;14(2):177-80.

PMID:
9089746
10.

The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.

Ferreri AJ, Govi S, Ponzoni M.

Curr Opin Oncol. 2013 Sep;25(5):470-9. doi: 10.1097/01.cco.0000432523.24358.15. Review.

PMID:
23942292
11.

Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.

Kuo SH, Chen LT, Wu MS, Kuo KT, Yeh KH, Doong SL, Yeh PY, Hsu HC, Tzeng YS, Lin CW, Lin JT, Cheng AL.

J Pathol. 2007 Feb;211(3):296-304.

PMID:
17167822
12.

Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma.

Kuo SH, Yeh PY, Chen LT, Wu MS, Lin CW, Yeh KH, Tzeng YS, Chen JY, Hsu PN, Lin JT, Cheng AL.

Blood. 2008 Oct 1;112(7):2927-34. doi: 10.1182/blood-2008-02-137513.

13.

De-escalating therapy in gastric aggressive lymphoma.

Cuccurullo R, Govi S, Ferreri AJ.

World J Gastroenterol. 2014 Jul 21;20(27):8993-7. doi: 10.3748/wjg.v20.i27.8993. Review.

14.

Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL.

Kuo SH, Chen LT, Lin CW, Yeh KH, Shun CT, Tzeng YS, Liou JM, Wu MS, Hsu PN, Cheng AL.

Blood. 2017 Jan 12;129(2):188-198. doi: 10.1182/blood-2016-04-713719.

PMID:
27864293
15.

Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.

Sumida T, Kitadai Y, Hiyama T, Shinagawa K, Tanaka M, Kodama M, Masuda H, Ito M, Tanaka S, Yoshihara M, Chayama K.

Cancer Sci. 2009 Jun;100(6):1075-81. doi: 10.1111/j.1349-7006.2009.01139.x.

16.

[Relationship between Helicobacter pylori infection and expression of connexin (Cx) 32 and Cx43 genes in gastric cancer and gastric precancerous lesions].

Xu CX, Jia Y, Yang WB, Wang F, Shen SR.

Zhonghua Yi Xue Za Zhi. 2008 Jun 10;88(22):1523-7. Chinese.

PMID:
18956631
17.

[Complete remission of diffuse large B-cell lymphoma of the stomach after eradication of Helicobacter pylori].

Høeg RT, Skau AM, Nørgaard P, Hansen PB.

Ugeskr Laeger. 2011 Sep 26;173(39):2425-6. Danish.

PMID:
21958489
18.

Helicobacter pylori CagA Translocation Is Closely Associated With the Expression of CagA-signaling Molecules in Low-grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma.

Kuo SH, Yeh KH, Chen LT, Lin CW, Hsu PN, Wu MS, Liou JM, Tsai HJ, Tzeng YS, Cheng AL.

Am J Surg Pathol. 2015 Jun;39(6):761-6. doi: 10.1097/PAS.0000000000000437.

PMID:
25871616
19.

Regression of gastric de novo diffuse large B-cell lymphoma following Helicobacter pylori eradication: a case report.

Saito M, Masutani M, Mabe K, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M, Tanino M.

Acta Gastroenterol Belg. 2016 Jul-Sep;79(3):367-369.

PMID:
27821034
20.

Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial.

Ferreri AJ, Govi S, Raderer M, Mulè A, Andriani A, Caracciolo D, Devizzi L, Ilariucci F, Luminari S, Viale E, Müllauer L, Dell'Oro S, Arcidiacono PG, Ponzoni M, Patti C.

Blood. 2012 Nov 1;120(18):3858-60. doi: 10.1182/blood-2012-06-438424. No abstract available.

Items per page

Supplemental Content

Support Center